Macitentan 10 mg tablet, once daily.

DRUG3 trials

Sponsors

Actelion, China-Japan Friendship Hospital

Conditions

Coronary Microvascular AnginaMacitentanNon-Coronary Obstructive AnginaPulmonary Arterial Hypertension

Early Phase 1

Evaluation of the Efficacy of MACitentan in the Treatment of CoronaryMICrovascular Angina (MACMIC)

RecruitingNCT06811831

China-Japan Friendship HospitalCoronary Microvascular Angina, Macitentan

Start: 2024-11-01End: 2026-10-01Target: 30Updated: 2025-02-06

Efficacy and Mechanisms of Macitentan for Non-Coronary Obstructive Angina

RecruitingNCT07392281

China-Japan Friendship HospitalNon-Coronary Obstructive Angina

Start: 2025-09-01End: 2027-08-31Target: 40Updated: 2026-02-06

Phase 3

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

TerminatedNCT01739400

ActelionPulmonary Arterial Hypertension

Start: 2013-09-10End: 2018-01-12Updated: 2019-04-16

Related Papers

Evaluation of Macitentan in Patients With Eisenmenger Syndrome

Circulation2018-12-28122 citations